Multidrug Resistance Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Modified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in India
Conditions: Pre-Extensively Drug-Resistant Pulmonary TB; Treatment Intolerant Multidrug-Resistant Pulmonary TB; Non-responsive Multidrug-Resistant Pulmonary TB Interventions: Drug: Linezolid; Drug: Bedaquiline; Drug: Pretomanid Sponsors: Tuberculosis Research Centre, India; International Union Against Tuberculosis and Lung Diseases; Sarvodaya Charitable Trust Hospital, Ghatkopar, Mumbai; Shatabdi Centenary Hospital, Govandi, Mumbai; KGMU, Lucknow; SN Medical College, Agra; BJ Medical College, Ahme dabad; Govt. Medical College, Surat; NITRD, New Delhi;...
Source: ClinicalTrials.gov - September 10, 2021 Category: Research Source Type: clinical trials

Hotspots, Households and Hospitals: Enhanced Drug-resistant Tuberculosis Case Finding in Namibia
Condition: Tuberculosis, Multidrug-Resistant Intervention: Sponsors: University of Namibia; UK Medical Research Council (MRC); European and Developing Countries Clinical Trials Partnership (EDCTP); Research Center Borstel; Imperial College London; University of Stellenbosch; National Taiwan University; Namibian National Tubercul osis and Leprosy Programme (NTLP); UK Foreign, Commonwealth& Development Office (FCDO) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 26, 2021 Category: Research Source Type: clinical trials